focus -WSS

focus

author：leisure time 2025-09-06 04:14:52 - browse：133

The back of three medicine containers, a bottle in between two boxes, all showing labels — coverage from STAT — Adobe

After a drug enters the market, it’s up to Food and Drug Administration regulators to ensure its continued safety and efficacy. A recent New York Times story suggests that, in the case of the popular asthma drug Singulair, the FDA fell short — both because the agency delayed action for years on reports from patient advocates and independent groups that the drug could cause suicidal thoughts, and because when it did add a warning label about its potential side effects in 2020, clinicians and patients still weren’t always aware of the risks.

Experts say that the Singulair incident highlights a flawed system, both in the U.S. and globally, for monitoring adverse reactions after a drug is on the market — one that will require extensive changes to address.

“The question is, how safe do you want to be?” said Ameet Sarpatwari, the assistant director of the Program on Regulation, Therapeutics, and Law at Brigham and Women’s Hospital. Ideally, he said, the FDA should be able to both stay on top of safety concerns and avoid unnecessarily restricting access to drugs. “Are we at the right balance? I think there are definitely situations for many drugs where you can say, no, we’re not really at the right balance, and the FDA should be taking a more aggressive stance in promoting patient safety.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Why Eli Lilly’s earnings didn’t quite live up to the hype

WSS

Latigo launches with $135 million for Vertex

ER docs worry over extreme heat as a 'mass casualty event'

ER docs worry over extreme heat as a 'mass casualty event'

Why don't Americans have at

Doctors on social media are being harassed and cyberbullied

Tome Biosciences co

focus

focus

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

A look at other Americans who have crossed into North Korea over the years

Psychedelics group wrestles with new pharma identity

15 die by electrocution after transformer explodes in northern India

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Websites selling Wegovy, Zepbound ingredients targeted by FDA

The cancer drug shortage isn’t new — and neither are the solutions

Study gives hint on South Asians’ higher risk of cardiovascular disease

Peter Hotez and the public health issue of online harassment

House passes resolution saying Israel isn't a 'racist or apartheid state'

knowledge

Robert Kennedy Jr.'s presidential campaign attracts GOP

Having children helps parents live longer, especially after age 80

Abbott's new heart device gets FDA advisory panel nod

Long Covid research funding gets a major boost from NIH

DeSantis says Trump could've 'come out more forcefully' during Jan. 6

Too many hospitalized Covid

Wikipedia

hotspot

leisure time

entertainment